Pfam Domains GO Terms
| HJURP C |
| SRF-TF |
| sinoatrial valve morphogenesis |
| primary heart field specification |
| sinoatrial valve development |
| nephron tubule epithelial cell differentiation |
| muscle cell fate determination |
| cellular response to trichostatin A |
| positive regulation of macrophage apoptotic process |
| response to trichostatin A |
| regulation of synaptic activity |
| epithelial cell proliferation involved in renal tubule morphogenesis |
| negative regulation of vascular endothelial cell proliferation |
| positive regulation of alkaline phosphatase activity |
| positive regulation of skeletal muscle cell differentiation |
| negative regulation of vascular associated smooth muscle cell migration |
| positive regulation of fear response |
| positive regulation of cell proliferation in bone marrow |
| positive regulation of behavioral fear response |
| regulation of sarcomere organization |
| regulation of cell proliferation in bone marrow |
| positive regulation of myeloid cell apoptotic process |
| glomerulus morphogenesis |
| germinal center formation |
| secondary heart field specification |
| AT DNA binding |
| regulation of germinal center formation |
| regulation of behavioral fear response |
| cellular response to parathyroid hormone stimulus |
| regulation of fear response |
| regulation of alkaline phosphatase activity |
| sarcoplasm |
| heart field specification |
| embryonic viscerocranium morphogenesis |
| regulation of macrophage apoptotic process |
| cardiac ventricle formation |
| positive regulation of protein homodimerization activity |
| cardiac chamber formation |
| response to parathyroid hormone |
| heart formation |
| cardiac muscle hypertrophy in response to stress |
| cardiac muscle adaptation |
| muscle hypertrophy in response to stress |
| specification of animal organ identity |
| muscle cell fate commitment |
| ventricular cardiac muscle cell differentiation |
| HMG box domain binding |
| mononuclear cell differentiation |
| monocyte differentiation |
| cellular response to fluid shear stress |
| negative regulation of vascular smooth muscle cell proliferation |
| positive regulation of cardiac muscle cell differentiation |
| regulation of vascular endothelial cell proliferation |
| platelet formation |
| regulation of skeletal muscle cell differentiation |
| platelet morphogenesis |
| melanocyte differentiation |
| regulation of protein homodimerization activity |
| regulation of vascular associated smooth muscle cell migration |
| positive regulation of myoblast differentiation |
| negative regulation of smooth muscle cell migration |
| positive regulation of cardiac muscle cell proliferation |
| regulation of AMPA receptor activity |
| positive regulation of skeletal muscle tissue development |
| B cell homeostasis |
| striated muscle adaptation |
| endochondral ossification |
| positive regulation of cardiocyte differentiation |
| positive regulation of behavior |
| replacement ossification |
| positive regulation of leukocyte apoptotic process |
| cardiac muscle hypertrophy |
| cartilage morphogenesis |
| regulation of myeloid cell apoptotic process |
| striated muscle hypertrophy |
| epithelial cell differentiation involved in kidney development |
| pigment cell differentiation |
| muscle adaptation |
| muscle hypertrophy |
| blood vessel remodeling |
| negative regulation of blood vessel endothelial cell migration |
| smooth muscle cell differentiation |
| activating transcription factor binding |
| positive regulation of cardiac muscle tissue growth |
| response to fluid shear stress |
| positive regulation of phosphatase activity |
| animal organ formation |
| regulation of cardiac muscle cell differentiation |
| regulation of NMDA receptor activity |
| negative regulation of endothelial cell proliferation |
| positive regulation of heart growth |
| positive regulation of bone mineralization |
| cell fate determination |
| developmental pigmentation |
| regulation of cardiac muscle cell proliferation |
| cell differentiation involved in kidney development |
| positive regulation of B cell proliferation |
| B cell proliferation |
| positive regulation of cardiac muscle tissue development |
| negative regulation of smooth muscle cell proliferation |
| embryonic cranial skeleton morphogenesis |
| positive regulation of biomineral tissue development |
| positive regulation of biomineralization |
| positive regulation of organ growth |
| negative regulation of endothelial cell migration |
| regulation of skeletal muscle tissue development |
| regulation of cardiocyte differentiation |
| skeletal muscle cell differentiation |
| regulation of vascular smooth muscle cell proliferation |
| glomerulus development |
| heart valve morphogenesis |
| lymphocyte homeostasis |
| regulation of myoblast differentiation |
| regulation of megakaryocyte differentiation |
| myotube differentiation |
| positive regulation of dephosphorylation |
| positive regulation of osteoblast differentiation |
| positive regulation of striated muscle cell differentiation |
| regulation of cardiac muscle tissue growth |
| regulation of smooth muscle cell migration |
| heart looping |
| heart valve development |
| regulation of B cell proliferation |
| excitatory postsynaptic potential |
| regulation of heart growth |
| regulation of glutamate receptor signaling pathway |
| cranial skeletal system development |
| determination of heart left/right asymmetry |
| negative regulation of epithelial cell migration |
| embryonic heart tube morphogenesis |
| chemical synaptic transmission, postsynaptic |
| renal tubule morphogenesis |
| regulation of synaptic transmission, glutamatergic |
| positive regulation of muscle organ development |
| leukocyte homeostasis |
| positive regulation of striated muscle tissue development |
| positive regulation of muscle tissue development |
| regulation of behavior |
| endochondral bone morphogenesis |
| regulation of dendritic spine development |
| outflow tract morphogenesis |
| cardiac ventricle morphogenesis |
| negative regulation of ossification |
| regulation of neurotransmitter receptor activity |
| regulation of bone mineralization |
| embryonic heart tube development |
| nephron tubule development |
| regulation of cardiac muscle tissue development |
| renal tubule development |
| chondrocyte differentiation |
| regulation of leukocyte apoptotic process |
| lymphocyte proliferation |
| cellular response to calcium ion |
| postsynapse |
| positive regulation of ossification |
| mononuclear cell proliferation |
| positive regulation of muscle cell differentiation |
| epithelial cell proliferation |
| cardiac muscle cell differentiation |
| neural crest cell differentiation |
| regulation of actomyosin structure organization |
| regulation of blood vessel endothelial cell migration |
| roof of mouth development |
| pigmentation |
| regulation of biomineral tissue development |
| regulation of biomineralization |
| positive regulation of protein binding |
| embryonic skeletal system morphogenesis |
| regulation of organ growth |
| nephron epithelium development |
| leukocyte proliferation |
| RNA polymerase II distal enhancer sequence-specific DNA binding |
| regulation of postsynaptic membrane potential |
| tissue remodeling |
| regulation of striated muscle cell differentiation |
| regulation of neurotransmitter secretion |
| regulation of synapse assembly |
| myeloid leukocyte differentiation |
| histone deacetylase binding |
| regulation of osteoblast differentiation |
| bone morphogenesis |
| cardiocyte differentiation |
| determination of left/right symmetry |
| cellular response to antibiotic |
| neuron migration |
| skeletal muscle tissue development |
| determination of bilateral symmetry |
| negative regulation of epithelial cell proliferation |
| specification of symmetry |
| nephron development |
| osteoblast differentiation |
| embryonic skeletal system development |
| cardiac chamber morphogenesis |
| cardiac ventricle development |
| B cell receptor signaling pathway |
| regulation of endothelial cell proliferation |
| kidney epithelium development |
| positive regulation of lymphocyte proliferation |
| positive regulation of mononuclear cell proliferation |
| regulation of striated muscle tissue development |
| skeletal muscle organ development |
| regulation of smooth muscle cell proliferation |
| regulation of muscle tissue development |
| regulation of muscle organ development |
| positive regulation of leukocyte proliferation |
| regulation of neurotransmitter transport |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| negative regulation of neuron apoptotic process |
| regulation of dendrite development |
| response to calcium ion |
| regulation of muscle cell differentiation |
| B cell activation |
| cellular response to transforming growth factor beta stimulus |
| mesenchymal cell differentiation |
| stem cell differentiation |
| regulation of endothelial cell migration |
| regulation of adaptive immune response |
| response to transforming growth factor beta |
| cardiac muscle tissue development |
| positive regulation of B cell activation |
| cardiac chamber development |
| positive regulation of developmental growth |
| regulation of cation channel activity |
| cartilage development |
| regulation of signaling receptor activity |
| regulation of phosphatase activity |
| positive regulation of binding |
| cellular response to lipopolysaccharide |
| regulation of synaptic plasticity |
| regulation of ossification |
| cellular response to metal ion |
| cellular response to molecule of bacterial origin |
| bone development |
| homeostasis of number of cells |
| striated muscle cell differentiation |
| negative regulation of neuron death |
| regulation of neuron apoptotic process |
| regulation of B cell activation |
| regulation of lymphocyte proliferation |
| regulation of mononuclear cell proliferation |
| regulation of dephosphorylation |
| cellular response to biotic stimulus |
| regulation of synapse organization |
| transcription regulatory region DNA binding |
| regulation of protein binding |
| myeloid cell differentiation |
| regulation of organelle assembly |
| regulation of epithelial cell migration |
| cellular response to inorganic substance |
| mesenchyme development |
| regulation of leukocyte proliferation |
| connective tissue development |
| regulation of myeloid cell differentiation |
| regulation of synapse structure or activity |
| nuclear chromatin |
| skeletal system morphogenesis |
| muscle cell differentiation |
| cell fate commitment |
| heart morphogenesis |
| regulation of ion transmembrane transporter activity |
| negative regulation of cell migration |
| positive regulation of growth |
| learning or memory |
| ossification |
| regulation of transmembrane transporter activity |
| kidney development |
| negative regulation of cell motility |
| regulation of transporter activity |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| striated muscle tissue development |
| renal system development |
| embryonic organ morphogenesis |
| antigen receptor-mediated signaling pathway |
| muscle organ development |
| muscle tissue development |
| cognition |
| muscle system process |
| response to antibiotic |
| epithelial tube morphogenesis |
| negative regulation of cellular component movement |
| regulation of neuron death |
| RNA polymerase II regulatory region sequence-specific DNA binding |
| response to lipopolysaccharide |
| urogenital system development |
| negative regulation of locomotion |
| response to molecule of bacterial origin |
| regulation of developmental growth |
| leukocyte differentiation |
| regionalization |
| regulation of cation transmembrane transport |
| regulation of epithelial cell proliferation |
| regulation of actin cytoskeleton organization |
| humoral immune response |
| regulation of supramolecular fiber organization |
| regulation of neurotransmitter levels |
| positive regulation of lymphocyte activation |
| positive regulation of neuron differentiation |
| response to metal ion |
| MAPK cascade |
| regulation of binding |
| lymphocyte activation |
| regulation of actin filament-based process |
| signal transduction by protein phosphorylation |
| chromatin binding |
| nuclear speck |
| cellular response to drug |
| positive regulation of leukocyte activation |
| positive regulation of cell activation |
| anterograde trans-synaptic signaling |
| chemical synaptic transmission |
| cell surface receptor signaling pathway involved in cell-cell signaling |
| regulation of membrane potential |
| cell morphogenesis involved in neuron differentiation |
| morphogenesis of an epithelium |
| embryonic organ development |
| pattern specification process |
| trans-synaptic signaling |
| modulation of chemical synaptic transmission |
| regulation of trans-synaptic signaling |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| immune response-activating cell surface receptor signaling pathway |
| regulation of hemopoiesis |
| synaptic signaling |
| positive regulation of neurogenesis |
| positive regulation of defense response |
| muscle structure development |
| regulation of ion transmembrane transport |
| immune response-regulating cell surface receptor signaling pathway |
| blood vessel development |
| protein heterodimerization activity |
| skeletal system development |
| regulation of neuron projection development |
| cellular response to growth factor stimulus |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| vasculature development |
| regulation of lymphocyte activation |
| cardiovascular system development |
| cellular response to lipid |
| heart development |
| response to growth factor |
| response to inorganic substance |
| positive regulation of nervous system development |
| regulation of cytoskeleton organization |
| cellular response to organic cyclic compound |
| positive regulation of cell development |
| cell population proliferation |
| cell morphogenesis involved in differentiation |
| hemopoiesis |
| immune response-activating signal transduction |
| regulation of transmembrane transport |
| tissue morphogenesis |
| embryonic morphogenesis |
| behavior |
| immune response-regulating signaling pathway |
| protein-containing complex |
| cellular response to organonitrogen compound |
| regulation of leukocyte activation |
| cellular response to hormone stimulus |
| hematopoietic or lymphoid organ development |
| adaptive immune response |
| activation of immune response |
| chordate embryonic development |
| regulation of cell activation |
| positive regulation of apoptotic process |
| immune system development |
| positive regulation of programmed cell death |
| embryo development ending in birth or egg hatching |
| tube morphogenesis |
| regulation of neuron differentiation |
| cellular response to nitrogen compound |
| regulation of growth |
| DNA-binding transcription factor activity |
| negative regulation of cell population proliferation |
| epithelial cell differentiation |
| intracellular membrane-bounded organelle |
| response to bacterium |
| regulation of plasma membrane bounded cell projection organization |
| positive regulation of cell death |
| regulation of ion transport |
| regulation of cell projection organization |
| cell morphogenesis |
| regulation of secretion by cell |
| regulation of defense response |
| positive regulation of hydrolase activity |
| regulation of secretion |
| neuron development |
| regulation of neurogenesis |
| cellular component morphogenesis |
| tube development |
| regulation of cell migration |
| response to lipid |
| negative regulation of transcription by RNA polymerase II |
| positive regulation of immune response |
| circulatory system development |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| response to hormone |
| regulation of cell motility |
| positive regulation of cell population proliferation |
| regulation of cellular localization |
| response to organic cyclic compound |
| apoptotic process |
| regulation of nervous system development |
| leukocyte activation |
| regulation of cell development |
| animal organ morphogenesis |
| regulation of cellular component biogenesis |
| cell migration |
| positive regulation of cell differentiation |
| protein phosphorylation |
| embryo development |
| regulation of locomotion |
| negative regulation of cell death |
| regulation of cellular component movement |
| response to organonitrogen compound |
| neuron differentiation |
| response to drug |
| programmed cell death |
| cellular response to oxygen-containing compound |
| regulation of anatomical structure morphogenesis |
| cell activation |
| localization of cell |
| cell motility |
| response to nitrogen compound |
| cell death |
| epithelium development |
| cell-cell signaling |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| positive regulation of immune system process |
| regulation of immune response |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| regulation of hydrolase activity |
| phosphorylation |
| regulation of organelle organization |
| response to other organism |
| response to external biotic stimulus |
| locomotion |
| response to biotic stimulus |
| negative regulation of RNA metabolic process |
| positive regulation of developmental process |
| nervous system process |
| negative regulation of cellular macromolecule biosynthetic process |
| positive regulation of catalytic activity |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| response to endogenous stimulus |
| regulation of response to stress |
| negative regulation of cellular biosynthetic process |
| generation of neurons |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| regulation of cell population proliferation |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| homeostatic process |
| cell development |
| regulation of immune system process |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| regulation of transport |
| immune response |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| system process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 3/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 7/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution